ArticleCurrent medical science2026
Parallel Mediating Roles of Illness Acceptance Attitudes Between Physical Symptoms and Quality of Life in Patients with Gastrointestinal Cancers.
Article in Current medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePhysical symptoms severely impair quality of life (QoL) in patients with gastrointestinal cancers (GICs). Although illness acceptance is recognized as a key mediator, the distinct rols of its two dimensions-active acceptance and negative acceptance-remain underexplored in the symptom-QoL pathway. This study aimed to explore their parallel mediating roles.
methodsIn this cross-sectional study, 301 inpatients with GICs completed the MD Anderson Symptom Inventory (MDASI), the 12-item Short Form Health Survey (SF-12), the Illness Cognition Questionnaire-Acceptance subscale (ICQ-A, measuring active acceptance), and the Medical Coping Modes Questionnaire (MCMQ, measuring negative acceptance). Parallel mediation analysis was performed using PROCESS Model 4 with bootstrap resampling (5,000 iterations).
resultsSymptom severity was negatively correlated with QoL (r = -0.69, P < 0.01) and active acceptance (r = -0.47, P < 0.01), and positively correlated with negative acceptance (r = 0.56, P < 0.01). Active acceptance was positively (r = 0.60) and negative acceptance negatively (r = -0.60) correlated with QoL (both P < 0.01). Mediation analysis revealed two significant indirect pathways: symptoms → reduced active acceptance → lower QoL, accounting for 23.92% of total effect (95% bootstrap CI [-0.068, -0.033]), and symptoms → increased negative acceptance → lower QoL, accounting for 25.36% of total effect (95% bootstrap CI [-0.074, -0.035]). Neither confidence interval contained zero.
conclusionBoth active acceptance and negative acceptance independently mediate the relationship between physical symptoms and QoL in patients with GICs. Active acceptance buffers the impact of symptoms, whereas negative acceptance exacerbates it. These findings support integrating psychological interventions that foster active acceptance and mitigate negative acceptance as a core component of symptom management to optimize QoL in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.